Proteomics landscape of radiation-induced cardiovascular disease: somewhere over the paradigm

Expert Rev Proteomics. 2017 Nov;14(11):987-996. doi: 10.1080/14789450.2017.1388743. Epub 2017 Oct 10.

Abstract

Epidemiological studies clearly show that thoracic or whole body exposure to ionizing radiation increases the risk of cardiac morbidity and mortality. Radiation-induced cardiovascular disease (CVD) has been intensively studied during the last ten years but the underlying molecular mechanisms are still poorly understood. Areas covered: Heart proteomics is a powerful tool holding promise for the future research. The central focus of this review is to compare proteomics data on radiation-induced CVD with data arising from proteomics of healthy and diseased cardiac tissue in general. In this context we highlight common and unique features of radiation-related and other heart pathologies. Future prospects and challenges of the field are discussed. Expert commentary: Data from comprehensive cardiac proteomics have deepened the knowledge of molecular mechanisms involved in radiation-induced cardiac dysfunction. State-of-the-art proteomics has the potential to identify novel diagnostic and therapeutic markers of this disease.

Keywords: Endothelial cell; PPAR alpha; fibrates; heart; ionizing radiation; label-free; proteomics; radiation therapy; statins.

Publication types

  • Review

MeSH terms

  • Animals
  • Biomarkers
  • Cardiovascular Diseases / etiology*
  • Cardiovascular Diseases / metabolism*
  • Humans
  • Proteome*
  • Proteomics
  • Radiation Injuries*
  • Radiation, Ionizing

Substances

  • Biomarkers
  • Proteome